According to a research report titled ‘Global Organ Preservation Market - Analysis By Preservation Technique (SCS, HMP, NMP, Others), Preservation Solutions, By Organ Type, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)’, available with Market Study Report, global organ preservation market was valued at USD 202.2 million in 2019 and is expected to grow at a substantial rate during the forecast period 2020-2025.
 

Report findings claim that increasing incidence of ailments such as chronic heart & kidney disease, COPD (chronic obstructive pulmonary disease), and end-stage organ failure, and mounting demand for healthcare products are influencing worldwide organ preservation industry growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2827954/
 

Substantial supply-demand imbalance in solid organ transplants coupled with technological advancements in organ preservation supply chain, prevalence of hypertension, rising geriatric population, and enhanced healthcare spending are also boosting market valuation.
 

Additionally, growing number of government initiatives for creating awareness about organ donation and incremental exposure to polluted environments are fueling industry expansion.
 

Factors such as pervasiveness of unhealthy lifestyle, consumption of alcohol, lack of physical activity, and smoking tobacco are leading causes for heart, kidney, and lung diseases, which is further augmenting the demand in global organ preservation market.
 

Despite the positive outlook, the COVID-19 pandemic severely affected this business sphere and acted as a deterrent to industry growth during 2020. However, several organ transplant and donation associations have recommenced activities of creating awareness and registering people for organ donations, thus boosting market outlook for the upcoming years.
 

Based on preservation technique, global organ preservation industry is classified into static cold storage, normothermic machine perfusion, hypothermic machine perfusion, and others. Among these, normothermic machine perfusion segment is touted to record commendable growth over the study period, owing to better transplantation results, efficient preservation of different organs, and reduced side effects post-transplantation.
 

By preservation solution, the industry segmentation comprises histidine-tryptophan-ketoglutarate (HTK), University of Wisconsin (UW), and others. HTK solution segment is likely to be favored in the coming years due to its properties of rapid homogenous cooling caused by less thickness and excellent visibility.
 

Moving on to organ type, the business vertical is split into liver, kidney, lung, heart, and others. Of these, kidney segment accounted for a majority market share in the recent years. However, lung preservation segment is projected to exhibit highest growth through 2025, due to increasing incidence of COPD and other chronic lung diseases.
 

On the regional front, Americas is expected to become a lucrative growth avenue in global organ preservation market in the upcoming years. This can be credited to factors such as escalating expenditure on healthcare, massive target population base, prevalence of life-threatening diseases, and rise in government initiatives and awareness programs.
 

Major players in the industry sphere are S.A.L.F. S.p.A., Global Transplant Solutions Inc. (GTS), Institut Georges Lopez (IGL), Organ Assist Products B.V., Preservation Solutions Inc., OrganOx Ltd., Dr. Franz Köhler Chemie GmbH, CryoLife Inc., Essential Pharmaceuticals LLC, Aarti Industries Ltd., Xvivo Perfusion AB, Dow Chemical Company, and Transmedics Group Inc.